LifePoint Health Inc (NASDAQ:LPNT)’s share price was down 5.8% during trading on Wednesday . The stock traded as low as $47.50 and last traded at $47.95. Approximately 871,902 shares traded hands during mid-day trading, an increase of 23% from the average daily volume of 710,651 shares. The stock had previously closed at $50.90.
Several equities analysts recently commented on LPNT shares. Credit Suisse Group started coverage on LifePoint Health in a report on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 target price on the stock. Zacks Investment Research raised LifePoint Health from a “sell” rating to a “hold” rating in a report on Monday, September 11th. Leerink Swann reissued an “outperform” rating and issued a $58.00 target price (down previously from $74.00) on shares of LifePoint Health in a report on Tuesday, October 31st. They noted that the move was a valuation call. SunTrust Banks set a $60.00 target price on LifePoint Health and gave the company a “hold” rating in a report on Thursday, October 12th. Finally, Raymond James Financial reissued a “market perform” rating on shares of LifePoint Health in a report on Monday, October 30th. Three research analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $59.14.
The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. The firm has a market cap of $1,889.99, a P/E ratio of 11.35, a PEG ratio of 1.13 and a beta of 0.67.
LifePoint Health declared that its board has initiated a stock repurchase plan on Friday, October 27th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
In other LifePoint Health news, Director Marguerite Kondracke sold 3,907 shares of the company’s stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total value of $174,760.11. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 8.76% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in LPNT. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of LifePoint Health by 10.8% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares during the period. Shelton Capital Management acquired a new stake in shares of LifePoint Health during the second quarter worth about $205,000. Capstone Investment Advisors Netherlands B.V. acquired a new stake in shares of LifePoint Health during the second quarter worth about $233,000. Airain ltd acquired a new stake in shares of LifePoint Health during the second quarter worth about $234,000. Finally, Parametrica Management Ltd acquired a new stake in shares of LifePoint Health during the third quarter worth about $282,000. Institutional investors and hedge funds own 99.18% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3126982/lifepoint-health-lpnt-shares-down-5-8.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.